Most important: Confirmation VB-111 is safe in 3 indications. With all trials and phases combined, this shows that VB-111 is safe in over 300 patients. It also shows that VB-111 is so far very effective in thyroid, ovarian and brain cancers.
Safety is a huge issue in these types of drugs, and VB-111 has shown to not only be safe but also safe when combined with other therapies.